The nation's top infectious disease expert expects COVID-19 vaccination to be made available for children aged 5 to 11 years by early November; Walmart recalls aromatherapy spray due to rare and deadly bacteria contamination; COVID-19–related brain fog has been found to persist in patients for months after infection.
As reported by Reuters, children aged 5 to 11 years will likely be able to be vaccinated against COVID-19 starting in early November. The chief medical advisor to President Joe Biden, Anthony Fauci, MD, said yesterday that he predicts the regulatory approval and recommendation from the CDC to be issued by the first or second week of November. Currently, FDA officials are reviewing the Pfizer/BioNTech application of its 2-dose vaccine in younger children, with a panel of outside advisers scheduled to meet on October 26. The CDC will meet to discuss their recommendations on November 2 and 3.
Approximately 3900 bottles of an essential-oil aromatherapy spray from Walmart are being recalled due to potential contamination with a rare and deadly bacteria, Burkholderia pseudomallei. Reported by NPR, Walmart's Better Homes & Gardens–branded Essential Oil Infused Aromatherapy Room Spray with Gemstones has been associated with 4 confirmed cases, with 2 cases being fatal. The bacteria is known to cause meliodosis, a difficult-to-diagnose and deadly condition that typically develops in tropical climates, especially Southeast Asia and northern Australia.
Reported by CNN, cognitive impairment from COVID-19, also known as brain fog, was found in a recent study o persist for months after infection, even in those without cases of severe disease or hospitalization, according to JAMA Network Open. In the study, findings indicated that nearly 1 in 4 patients with COVID-19 from the Mount Sinai Health System registry experienced a cognitive-related issue, with hospitalized individuals shown to be more likely to have brain fog after infection. Overall, 23% of patients reported issues with memory recall, 18% showed deficits in their cognitive processing speed, and 15% had deficits in phonemic fluency in their speaking.
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen